<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39329962</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1467-3045</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Current issues in molecular biology</Title><ISOAbbreviation>Curr Issues Mol Biol</ISOAbbreviation></Journal><ArticleTitle>mRNA Fragmentation Pattern Detected by SHAPE.</ArticleTitle><Pagination><StartPage>10249</StartPage><EndPage>10258</EndPage><MedlinePgn>10249-10258</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/cimb46090610</ELocationID><Abstract><AbstractText>The success of messenger RNA (mRNA) vaccines in controlling COVID-19 has warranted further developments in new technology. Currently, their quality control process largely relies on low-resolution electrophoresis for detecting chain breaks. Here, we present an approach using multi-primer reverse transcription sequencing (MPRT-seq) to identify degradation fragments in mRNA products. Using this in-house-made mRNA containing two antigens and untranslated regions (UTRs), we analyzed the mRNA completeness and degradation pattern at a nucleotide resolution. We then analyzed the sensitive base sequence and its correlation with the secondary structure. Our MPRT-seq mapping shows that certain sequences on the 5' of bulge-stem-loop structures can result in preferential chain breaks. Our results agree with commonly used capillary electrophoresis (CE) integrity analysis but at a much higher resolution, and can improve mRNA stability by providing information to remove sensitive structures or sequences in the mRNA sequence design.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Changrui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>19410711000</GrantID><Agency>Foundation of Shanghai Science and Technology Committee</Agency><Country /></Grant><Grant><GrantID>19410741800</GrantID><Agency>Shanghai Science and Technology Commission grant</Agency><Country /></Grant><Grant><GrantID>SHXYFYG202304</GrantID><Agency>Medicine-Engineering Interdisciplinary Project of Shanghai Xuhui District Dental Center</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Issues Mol Biol</MedlineTA><NlmUniqueID>100931761</NlmUniqueID><ISSNLinking>1467-3037</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">degradation</Keyword><Keyword MajorTopicYN="N">freeze–thaw cycles</Keyword><Keyword MajorTopicYN="N">long-term storage</Keyword><Keyword MajorTopicYN="N">mRNA stability</Keyword><Keyword MajorTopicYN="N">mRNA structure</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>9</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39329962</ArticleId><ArticleId IdType="pmc">PMC11431040</ArticleId><ArticleId IdType="doi">10.3390/cimb46090610</ArticleId><ArticleId IdType="pii">cimb46090610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang E., Liu X., Li M., Zhang Z., Song L., Zhu B., Wu X., Liu J., Zhao D., Li Y. Advances in COVID-19 mRNA vaccine development. Signal Transduct. Target. Ther. 2022;7:1–31. doi: 10.1038/s41392-022-00950-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00950-y</ArticleId><ArticleId IdType="pmc">PMC8940982</ArticleId><ArticleId IdType="pubmed">35322018</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber K. mRNA pioneers refocus on therapeutics. Nat. Rev. Drug Discov. 2022;21:699–701. doi: 10.1038/d41573-022-00156-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41573-022-00156-5</ArticleId><ArticleId IdType="pubmed">36109614</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid K., Padda J., Khedr A., Ismail D., Zubair U., Al-Ewaidat O.A., Padda S., Cooper A.C., Jean-Charles G. HIV and Messenger RNA (mRNA) Vaccine. Cureus. 2021;13:e161972021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341208</ArticleId><ArticleId IdType="pubmed">34367800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C., Zhang Y., Liu X., Hou F., Cai R., Yu Z., Liu F., Yang G., Ding J., Xu J., et al. Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine. Antivir. Res. 2023;212:105556. doi: 10.1016/j.antiviral.2023.105556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2023.105556</ArticleId><ArticleId IdType="pmc">PMC9985518</ArticleId><ArticleId IdType="pubmed">36871919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutikuppala L.V.S., Kourampi I., Kanagala R.S.D., Bhattacharjee P., Boppana S.H. Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses. Med. Sci. 2024;12:28. doi: 10.3390/medsci12020028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medsci12020028</ArticleId><ArticleId IdType="pmc">PMC11130901</ArticleId><ArticleId IdType="pubmed">38804384</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao R., Xie C., Xia X. Recent progress in mRNA cancer vaccines. Hum. Vaccines Immunother. 2024;20:2307187. doi: 10.1080/21645515.2024.2307187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2024.2307187</ArticleId><ArticleId IdType="pmc">PMC10826636</ArticleId><ArticleId IdType="pubmed">38282471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball R.L., Bajaj P., Whitehead K. Achieving long-term stability of lipid nanoparticles: Examining the effect of pH, temperature, and lyophilization. Int. J. Nanomed. 2016;ume 12:305–315. doi: 10.2147/IJN.S123062.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S123062</ArticleId><ArticleId IdType="pmc">PMC5221800</ArticleId><ArticleId IdType="pubmed">28115848</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabre A.-L., Colotte M., Luis A., Tuffet S., Bonnet J. An efficient method for long-term room temperature storage of RNA. Eur. J. Hum. Genet. 2013;22:379–385. doi: 10.1038/ejhg.2013.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2013.145</ArticleId><ArticleId IdType="pmc">PMC3925273</ArticleId><ArticleId IdType="pubmed">23860045</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones K.L., Drane D., Gowans E.J. Long-Term Storage of DNA-Free RNA for use in Vaccine Studies. BioTechniques. 2007;43:675–681. doi: 10.2144/000112593.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000112593</ArticleId><ArticleId IdType="pmc">PMC4526277</ArticleId><ArticleId IdType="pubmed">18072597</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson H.S., Wang Y., Muller R., Edelman D.C. Long-term stability of total RNA in RNAstable(R) as evaluated by expression microarray. Biopreserv Biobank. 2015;13:114–122. doi: 10.1089/bio.2014.0068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2014.0068</ArticleId><ArticleId IdType="pmc">PMC4442560</ArticleId><ArticleId IdType="pubmed">25826008</ArticleId></ArticleIdList></Reference><Reference><Citation>Blenke E.O., Örnskov E., Schöneich C., Nilsson G.A., Volkin D.B., Mastrobattista E., Almarsson Ö., Crommelin D.J. The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case. J. Pharm. Sci. 2022;112:386–403. doi: 10.1016/j.xphs.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2022.11.001</ArticleId><ArticleId IdType="pmc">PMC9637289</ArticleId><ArticleId IdType="pubmed">36351479</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm M.R., Poland G.A. Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy. Vaccine. 2020;39:457–459. doi: 10.1016/j.vaccine.2020.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.12.017</ArticleId><ArticleId IdType="pmc">PMC7723768</ArticleId><ArticleId IdType="pubmed">33339671</ArticleId></ArticleIdList></Reference><Reference><Citation>Oivanen M., Kuusela S., Lönnberg H. Kinetics and Mechanisms for the Cleavage and Isomerization of the Phosphodiester Bonds of RNA by Brønsted Acids and Bases. Chem. Rev. 1998;98:961–990. doi: 10.1021/cr960425x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr960425x</ArticleId><ArticleId IdType="pubmed">11848921</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogocki D., Schoneich C. Chemical stability of nucleic acid-derived drugs. J. Pharm. Sci. 2000;89:443–456. doi: 10.1002/(SICI)1520-6017(200004)89:4&lt;443::AID-JPS2&gt;3.0.CO;2-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1520-6017(200004)89:4&lt;443::AID-JPS2&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">10737906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauger D.M., Cabral B.J., Presnyak V., Su S.V., Reid D.W., Goodman B., Link K., Khatwani N., Reynders J., Moore M.J., et al. mRNA structure regulates protein expression through changes in functional half-life. Proc. Natl. Acad. Sci. USA. 2019;116:24075–24083. doi: 10.1073/pnas.1908052116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1908052116</ArticleId><ArticleId IdType="pmc">PMC6883848</ArticleId><ArticleId IdType="pubmed">31712433</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergonzo C., Grishaev A., Bottaro S. Conformational heterogeneity of UCAAUC RNA oligonucleotide from molecular dynamics simulations, SAXS, and NMR experiments. RNA. 2022;28:937–946. doi: 10.1261/rna.078888.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.078888.121</ArticleId><ArticleId IdType="pmc">PMC9202585</ArticleId><ArticleId IdType="pubmed">35483823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wayment-Steele H.K., Kim D.S., Choe C.A., Nicol J.J., Wellington-Oguri R., Watkins A.M., Sperberg R.A.P., Huang P.-S., Participants E., Das R. Theoretical basis for stabilizing messenger RNA through secondary structure design. Nucleic Acids Res. 2021;49:10604–10617. doi: 10.1093/nar/gkab764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab764</ArticleId><ArticleId IdType="pmc">PMC8499941</ArticleId><ArticleId IdType="pubmed">34520542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson K.A., Merino E.J., Weeks K.M. RNA SHAPE chemistry reveals nonhierarchical interactions dominate equilibrium structural transitions in tRNA(Asp) transcripts. J. Am. Chem. Soc. 2005;127:4659–4667. doi: 10.1021/ja0436749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja0436749</ArticleId><ArticleId IdType="pubmed">15796531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson K.A., Merino E.J., Weeks K.M. Selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE): Quantitative RNA structure analysis at single nucleotide resolution. Nat. Protoc. 2006;1:1610–1616. doi: 10.1038/nprot.2006.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.249</ArticleId><ArticleId IdType="pubmed">17406453</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasa S.M., Guex N., Wilkinson K.A., Weeks K.M., Giddings M.C. ShapeFinder: A software system for high-throughput quantitative analysis of nucleic acid reactivity information resolved by capillary electrophoresis. RNA. 2008;14:1979–1990. doi: 10.1261/rna.1166808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.1166808</ArticleId><ArticleId IdType="pmc">PMC2553743</ArticleId><ArticleId IdType="pubmed">18772246</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Gao B., Sabnis R., Sun Q. RNAdegformer: Accurate prediction of mRNA degradation at nucleotide resolution with deep learning. Briefings Bioinform. 2023;24:bbac581. doi: 10.1093/bib/bbac581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbac581</ArticleId><ArticleId IdType="pmc">PMC9851316</ArticleId><ArticleId IdType="pubmed">36633966</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppek K., Byeon G.W., Kladwang W., Wayment-Steele H.K., Kerr C.H., Xu A.F., Kim D.S., Topkar V.V., Choe C., Rothschild D., et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat. Commun. 2022;13:1–22. doi: 10.1038/s41467-022-28776-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28776-w</ArticleId><ArticleId IdType="pmc">PMC8940940</ArticleId><ArticleId IdType="pubmed">35318324</ArticleId></ArticleIdList></Reference><Reference><Citation>Patiño-Guillén G., Pešović J., Panić M., Savić-Pavićević D., Bošković F., Keyser U.F. Single-molecule RNA sizing enables quantitative analysis of alternative transcription termination. Nat. Commun. 2024;15:1–12. doi: 10.1038/s41467-024-45968-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-45968-8</ArticleId><ArticleId IdType="pmc">PMC10894232</ArticleId><ArticleId IdType="pubmed">38402271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zhang L., Lin A., Xu C., Li Z., Liu K., Liu B., Ma X., Zhao F., Jiang H., et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 2023;621:396–403. doi: 10.1038/s41586-023-06127-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06127-z</ArticleId><ArticleId IdType="pmc">PMC10499610</ArticleId><ArticleId IdType="pubmed">37130545</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogeser M., Seger C. A decade of HPLC–MS/MS in the routine clinical laboratory—Goals for further developments. Clin. Biochem. 2008;41:649–662. doi: 10.1016/j.clinbiochem.2008.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2008.02.017</ArticleId><ArticleId IdType="pubmed">18374660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson I.D. High-performance liquid chromatography-mass spectrometry (HPLC-MS)-based drug metabolite profiling. Methods Mol. Biol. 2011;708:173–190.</Citation><ArticleIdList><ArticleId IdType="pubmed">21207290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameedat F., Hawamdeh S., Alnabulsi S., Zayed A. High Performance Liquid Chromatography (HPLC) with Fluorescence Detection for Quantification of Steroids in Clinical, Pharmaceutical, and Environmental Samples: A Review. Molecules. 2022;27:1807. doi: 10.3390/molecules27061807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27061807</ArticleId><ArticleId IdType="pmc">PMC8949805</ArticleId><ArticleId IdType="pubmed">35335170</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlanda S.F., Breitfeld M., Dietsche C.L., Dittrich P.S. Recent Advances in Microfluidic Technology for Bioanalysis and Diagnostics. Anal Chem. 2021;93:311–331. doi: 10.1021/acs.analchem.0c04366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04366</ArticleId><ArticleId IdType="pubmed">33170661</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunter H.M., Idrisoglu S., Singh S., Han D.J., Ariens E., Peters J.R., Wong T., Cheetham S.W., Xu J., Rai S.K., et al. mRNA vaccine quality analysis using RNA sequencing. Nat. Commun. 2023;14:1–12. doi: 10.1038/s41467-023-41354-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41354-y</ArticleId><ArticleId IdType="pmc">PMC10514319</ArticleId><ArticleId IdType="pubmed">37735471</ArticleId></ArticleIdList></Reference><Reference><Citation>Motorin Y., Marchand V. Analysis of RNA Modifications by Second- and Third-Generation Deep Sequencing: 2020 Update. Genes. 2021;12:278. doi: 10.3390/genes12020278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12020278</ArticleId><ArticleId IdType="pmc">PMC7919787</ArticleId><ArticleId IdType="pubmed">33669207</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanasopoulou K., Boti M.A., Adamopoulos P.G., Skourou P.C., Scorilas A. Third-Generation Sequencing: The Spearhead towards the Radical Transformation of Modern Genomics. Life. 2021;12:30. doi: 10.3390/life12010030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12010030</ArticleId><ArticleId IdType="pmc">PMC8780579</ArticleId><ArticleId IdType="pubmed">35054423</ArticleId></ArticleIdList></Reference><Reference><Citation>Satam H., Joshi K., Mangrolia U., Waghoo S., Zaidi G., Rawool S., Thakare R.P., Banday S., Mishra A.K., Das G., et al. Next-Generation Sequencing Technology: Current Trends and Advancements. Biology. 2023;12:997. doi: 10.3390/biology12070997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12070997</ArticleId><ArticleId IdType="pmc">PMC10376292</ArticleId><ArticleId IdType="pubmed">37508427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Sotcheff S.L., Routh A.L. Next-generation sequencing: A new avenue to understand viral RNA–protein interactions. J. Biol. Chem. 2022;298:101924. doi: 10.1016/j.jbc.2022.101924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101924</ArticleId><ArticleId IdType="pmc">PMC8994257</ArticleId><ArticleId IdType="pubmed">35413291</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Otsuka K., Kawai T. Recent advances in microscale separation techniques for glycome analysis. J. Sep. Sci. 2024;47:e24001702024. doi: 10.1002/jssc.202400170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jssc.202400170</ArticleId><ArticleId IdType="pubmed">38863084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu T., Klein L.J., Ha S., Rustandi R.R. High-Resolution capillary electrophoresis separation of large RNA under non-aqueous conditions. J. Chromatogr. A. 2020;1618:460875. doi: 10.1016/j.chroma.2020.460875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2020.460875</ArticleId><ArticleId IdType="pubmed">31982098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei B., Goyon A., Zhang K. Analysis of therapeutic nucleic acids by capillary electrophoresis. J. Pharm. Biomed. Anal. 2022;219:114928. doi: 10.1016/j.jpba.2022.114928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2022.114928</ArticleId><ArticleId IdType="pubmed">35853263</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantri P., Juneja B., Henderson S., Koufos E., Moon Y., Dayeh D.M., Di Grandi D., Fu Y., Muthusamy K., Ihnat P.M., et al. Comparison of capillary electrophoresis-based methods for the analytical characterization of purity and stability of in vitro transcribed mRNA. J. Pharm. Biomed. Anal. 2024;249:116352. doi: 10.1016/j.jpba.2024.116352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2024.116352</ArticleId><ArticleId IdType="pubmed">39029354</ArticleId></ArticleIdList></Reference><Reference><Citation>Muneer A., Fati S.M., Arifin Akbar N., Agustriawan D., Tri Wahyudi S. iVaccine-Deep: Prediction of COVID-19 mRNA vaccine degradation using deep learning. J. King Saud. Univ. Comput. Inf. Sci. 2022;34:7419–7432. doi: 10.1016/j.jksuci.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jksuci.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8513509</ArticleId><ArticleId IdType="pubmed">38620874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloczewiak M., Banks J.M., Jin L., Brader M.L. A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines. Mol. Pharm. 2022;19:2022–2031. doi: 10.1021/acs.molpharmaceut.2c00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.2c00092</ArticleId><ArticleId IdType="pmc">PMC9257798</ArticleId><ArticleId IdType="pubmed">35715255</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaid T.S., Mazaar H., Alqahtani M.S., Raweh A.A., Alakwaa W. Deep sequence modelling for predicting COVID-19 mRNA vaccine degradation. PeerJ Comput. Sci. 2021;7:e5972021. doi: 10.7717/peerj-cs.597.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj-cs.597</ArticleId><ArticleId IdType="pmc">PMC8237341</ArticleId><ArticleId IdType="pubmed">34239977</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>